Completed PHASE4 INTERVENTIONAL 2-arm NCT03626298

Efficacy and Tolerability of Nicotinamide Plus Cream for Moderate Acne Vulgaris in Indonesia

Efficacy and Tolerability of Nicotinamide Plus Cream for Moderate Acne Vulgaris in Indonesia: A Multicenter Clinical Trial

Sponsor: Rumah Sakit Pusat Angkatan Darat Gatot Soebroto

Conditions Acne Vulgaris

Interventions Adapalene Nicotinamide, ABA and Zinc PCA Placebos

Updated 4 times since 2018 Last updated: Aug 7, 2018 Started: Aug 1, 2016 Primary completion: Dec 31, 2016 Completion: Apr 30, 2018

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE4 trial investigates Acne Vulgaris and is currently completed. Rumah Sakit Pusat Angkatan Darat Gatot Soebroto leads this study, which shows 4 recorded versions since 2016 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE4
Jul 2024 — Sep 2024 [monthly]

Completed PHASE4
Jan 2021 — Jul 2024 [monthly]

Completed PHASE4
Sep 2018 — Jan 2021 [monthly]

Completed PHASE4

First recorded

Aug 2016

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Rumah Sakit Pusat Angkatan Darat Gatot Soebroto

Data source: Rumah Sakit Pusat Angkatan Darat Gatot Soebroto

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.